Market Report, "Venezuela Pharmaceuticals & Healthcare Report Q1 2014", Published
We expect the situation in Venezuela to worsen under a new law which will empower President Nicolas Maduro to enact legislation without approval from parliament, a new tool in what the authorities have called an 'economic war' against business owners, the opposition and foreign influences. The doubledigit pharmaceutical market growth is largely due to high inflation. In terms of real growth, we forecast the pharmaceutical market will experience contraction between 2013 and 2017 (President Maduro's first term), indicating a highly...
View full press release